Rosenblatt Reiterates Buy Rating for Cerebras Systems, Sets $300 Target
Rosenblatt maintains a positive outlook on Cerebras Systems with a reiterated buy rating and a $300 price target, a 65.21% upside from the current price.
Key Points
- Rosenblatt reiterated its buy rating for Cerebras Systems, setting a price target of $300 on June 24, 2026.
- Rosenblatt's $300 price target implies 65.21% upside from Cerebras Systems Inc.'s ($CBRS) current $181.59 share price.
- Cerebras Systems traded at $225.85 on Wednesday, with a market cap of about $49.3 billion and a P/E ratio of 534.4.
- Multiple analysts, including Wedbush and Morgan Stanley, also maintained buy ratings, with targets ranging from $273 to $300.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 24, 2026, Rosenblatt reiterated its buy rating for Cerebras Systems Inc. (NasdaqGS: CBRS), setting a price target of $300. Shares of Cerebras traded around $225.85 on Wednesday, reflecting ongoing interest in the company's performance.
Rosenblatt vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Analysts Set New Price Targets
On June 24, 2026, Rosenblatt maintained its buy rating for Cerebras Systems, setting a target price of $300. Other firms, including Wedbush and Morgan Stanley, also maintained their buy ratings with target prices of $280 and $273, respectively. Needham reiterated its buy rating with a $300 target, while Craig-Hallum initiated coverage with a buy rating and a $325 target. Mizuho and Morgan Stanley also initiated coverage earlier in June with buy ratings and target prices of $300 and $250.
Cerebras Systems Inc. Stock Up 1.4%
Shares of Cerebras Systems (NasdaqGS: CBRS) traded near $225.85 on Wednesday. The company has a market cap of approximately $49.3 billion and a P/E ratio of 534.4, with a forward P/E of 266.3. The stock's 52-week range is between $196.73 and $386.34, with a 50-day moving average of $244.44. Cerebras has a current ratio of 2.15 and a quick ratio of 1.64, indicating solid liquidity, while its debt-to-equity ratio stands at 19.5.
$CBRS price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Cerebras Systems reported revenue of about $510 million, showing growth of 14.7%. The company's earnings per share (EPS) stood at $0.42, with a net margin of 46.6% and a return on equity (ROE) of 38.4%. The next earnings report is expected on June 23, 2026.
Insider Buying and Selling at Cerebras Systems Inc.
On June 11, 2026, insider Susan Lior made two significant transactions involving 13,466,197 shares of Cerebras Systems. The transactions were not part of a pre-planned trading program.
About Cerebras Systems
Cerebras Systems Inc. is a technology company based in Sunnyvale, California, specializing in semiconductors. Founded in 2015, the company designs and manufactures an AI compute platform that includes proprietary systems and software. Its innovative wafer-scale engine aims to deliver superior performance for AI applications. The company serves a diverse range of clients, including hyperscalers and AI-native businesses, with operations spanning the U.S., Europe, the Middle East, and beyond.
Bottom Line
Rosenblatt's reiteration of its buy rating for Cerebras Systems highlights confidence in the company's future prospects. Investors track such analyst ratings closely as they can influence market perceptions and stock performance. As always, it's important to remember that these ratings are based on past performance and expectations, not guarantees of future results.
Get Cerebras Systems Inc. alerts
New 13F filings, insider trades, and analyst moves on $CBRS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.